We are live on
!
Find out more
TI
Telemetry Investments Portfolio holdings
AUM
$63.3M
1-Year Est. Return
0.06%
This Fund
S&P 500
This Quarter
Est. Return
+24.81%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
–
AUM
$197M
AUM Growth
+$40M
(+26%)
Cap. Flow
+$18.5M
Cap. Flow
% of AUM
9.4%
Top 10 Holdings %
Top 10 Hldgs %
66.77%
Holding
173
New
40
Increased
28
Reduced
21
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ELLI
Ellie Mae Inc
ELLI
|
+$1.44M |
| 2 |
IDTI
Integrated Device Technology I
IDTI
|
+$1.28M |
| 3 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$784K |
| 4 |
Matinas BioPharma
MTNB
|
+$700K |
| 5 |
Boeing
BA
|
+$693K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$4.17M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$2.77M |
| 3 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
+$2.56M |
| 4 |
Goldman Sachs
GS
|
+$1.75M |
| 5 |
SCG
Scana
SCG
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.08% |
| 2 | Communication Services | 1.96% |
| 3 | Technology | 1.47% |
| 4 | Materials | 0.76% |
| 5 | Industrials | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZSAN
26
DELISTED
Zosano Pharma Corporation
ZSAN
| $1.16M | 0.59% |
6,938
+680
| +11% | +$83.3K |
|
|
VRAY
27
CALL
DELISTED
ViewRay, Inc.
VRAY
| $979K | 0.5% |
132,500
+82,500
| +165% | +$636K |
|
28
Aclaris Therapeutics
ACRS
$726M
| $893K | 0.45% |
149,004
+50,504
| +51% | +$335K |
|
|
USG
29
DELISTED
Usg
USG
| $816K | 0.41% |
18,854
+10,000
| +113% | +$431K |
|
|
TCON
30
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $811K | 0.41% |
2,961
-1,874
| -39% | -$406K |
|
|
ARRS
31
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $790K | 0.4% |
+25,000
| New | +$784K |
|
32
Rigel Pharmaceuticals
RIGL
$681M
| $771K | 0.39% |
30,000
+4,000
| +15% | +$91.4K |
|
|
VRAY
33
DELISTED
ViewRay, Inc.
VRAY
| $739K | 0.38% |
100,000
-75,000
| -43% | -$578K |
|
|
ROSE
34
DELISTED
Rosehill Resources Inc. Class A
ROSE
| $714K | 0.36% |
210,024
-39,009
| -16% | -$121K |
|
|
35
Matinas BioPharma
MTNB
$1.88M
| $708K | 0.36% |
+13,000
| New | +$700K |
|
|
36
Boeing
BA
$171B
| $687K | 0.35% |
+1,800
| New | +$693K |
|
|
S
37
DELISTED
Sprint Corporation
S
| $655K | 0.33% |
115,997
+54,600
| +89% | +$338K |
|
|
STML
38
DELISTED
Stemline Therapeutics, Inc.
STML
| $642K | 0.33% |
50,000
+8,412
| +20% | +$95.1K |
|
|
SBBP
39
DELISTED
Strongbridge Biopharma plc.
SBBP
| $620K | 0.31% |
+124,544
| New | +$613K |
|
40
PUT
Moderna
MRNA
$21.8B
| $610K | 0.31% |
+30,000
| New | +$557K |
|
|
DERM
41
CALL
DELISTED
Dermira, Inc.
DERM
| $607K | 0.31% |
+44,800
| New | +$374K |
|
42
Corvus Pharmaceuticals
CRVS
$1.12B
| $604K | 0.31% |
150,199
+15,076
| +11% | +$63.6K |
|
43
Globalstar
GSAT
$10.7B
| $603K | 0.31% |
93,434
+31,999
| +52% | +$272K |
|
|
MXWL
44
DELISTED
Maxwell Technologies Inc
MXWL
| $598K | 0.3% |
+133,802
| New | +$526K |
|
|
OAK
45
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $546K | 0.28% |
+11,000
| New | +$478K |
|
46
Avista
AVA
$3.34B
| $496K | 0.25% |
12,220
-780
| -6% | -$32.1K |
|
47
United States Natural Gas Fund
UNG
$456M
| $493K | 0.25% |
+5,250
| New | +$525K |
|
48
Travere Therapeutics
TVTX
$5.2B
| $491K | 0.25% |
+21,695
| New | +$479K |
|
|
FNSR
49
DELISTED
Finisar Corp
FNSR
| $487K | 0.25% |
+21,000
| New | +$479K |
|
|
ONCE
50
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $467K | 0.24% |
+4,100
| New | +$301K |
|
Similar funds
SF
CAM
SCFS
LCH
SGMPI
HJMC
AI
DFAM
Telemetry Investments's Q1 2019 Portfolio in Review
As of Q1 2019, Telemetry Investments held 173 positions worth $197M, up 26% from $157M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Telemetry Investments deployed $18.5M of net new capital in Q1 2019, opening 40 new positions and adding to 28 existing holdings. Its largest new stake was Ellie Mae Inc: 16,628 shares worth $1.64M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Communication Services and Technology.
On the sell side, the largest reduction was Kadmon Holdings, Inc., an estimated $2.56M trimmed.
- Telemetry Investments's largest Q1 2019 buy was Ellie Mae Inc: 16,628 shares worth $1.64M.
- Telemetry Investments added most to Integrated Device Technology I in Q1 2019, an estimated $1.28M increase.
- Telemetry Investments's biggest Q1 2019 reduction was Kadmon Holdings, Inc., cutting an estimated $2.56M.
- Telemetry Investments fully exited State Street Financial Select Sector SPDR ETF in Q1 2019, selling an estimated $4.17M.
- Telemetry Investments's ten largest holdings make up 67% of its $197M portfolio in Q1 2019.
- Telemetry Investments opened 40 new positions and closed 71 in Q1 2019.
- Telemetry Investments's portfolio value rose 26% quarter-over-quarter to $197M.
Based on Telemetry Investments's 13F filing for Q1 2019, filed 15 May 2019.